In tumors, PD-1 or CTLA-4 is expressed on CD8+ T cells and binds to PD-L1 or CD80/CD86 expressed on tumor cells and tumor-infiltrating myeloid cells (e.g., TAMs), respectively. The gene discussed is CD80; the disease is neoplasm.